Achievement of target A1C levels with negligible hypoglycemia and low glucose variability in youth with short-term type 1 diabetes and residual β-cell function

Diabetes Care

Volumn 35, Issue 4, 2012, Pages 817-820

  Sherr, Jennifer ^a,h   Tamborlane, William V ^a,h   Xing, Dongyuan ^b   Tsalikian, Eva ^c,g   Mauras, Nelly ^d   Buckingham, Bruce ^e   White, Neil H ^f,i   Arbelaez, Ana Maria ^f,i   Beck, Roy W ^b   Kollman, Craig ^b   Ruedy, Katrina ^b   Tansey, Michael J ^g   Coffey, Julie ^g   Cabbage, Joanne ^g   Fox, Larry A ^d   Englert, Kim ^d   Permuy, Joe ^d   Wilson, Darrell M ^e   Clinton, Paula ^e   Caswell, Kimberly ^e   Weinzimer, Stuart A ^h   Steffen, Amy ^h   Weyman, Kate ^h   Zgorski, Melinda ^h   Tichy, Eileen ^h   Levandoski, Lucy ⁱ   Starnes, Angie ⁱ   Stevens, Beth ^b   Grave, Gilman D ^j   Winer, Karen K ^j   Leschek, Ellen ^j   Sperling, Mark ^k   Becker, Dorothy M ^k   Cleary, Patricia ^k   Greenbaum, Carla ^k   Moran, Antoinette ^k   Steffes, Michael W ^l   Bucksa, Jean M ^l   Nowicki, Maren L ^l   Makky, Vicky ^l   more..

^a YALE UNIVERSITY   (United States)

^b JAEB CENTER FOR HEALTH RESEARCH   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d NEMOURS CHILDREN S CLINIC   (United States)

^e STANFORD UNIVERSITY   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ WASHINGTON UNIVERSITY   (United States)

^j NATIONAL INSTITUTES OF HEALTH   (United States)

^k Data and Safety Monitoring Board   (United States)

^l University of Minnesota Central Laboratory   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; B LYMPHOCYTE; BLOOD GLUCOSE MONITORING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; LONG TERM EXPOSURE; LYMPHOCYTE FUNCTION; MALE; OUTCOME ASSESSMENT; SCHOOL CHILD; TREATMENT DURATION;

ADOLESCENT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; INSULIN INFUSION SYSTEMS; INSULIN-SECRETING CELLS; MALE; SINGLE-BLIND METHOD; TIME FACTORS;

EID: 84862105157     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2190     Document Type: Article

References (15)

1. The Diabetes Control and Complications Trial Research Group. Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. Ann Intern Med 1998;128:517-523
2. Fox LA, Beck RW, Xing D; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Variation of interstitial glucose measurements assessed by continuous glucose monitors in healthy, nondiabetic individuals. Diabetes Care 2010;33:1297-1299
3. Tamborlane WV, Beck RW, Bode BW, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476
4. Beck RW, Hirsch IB, Laffel L, et al.; Juvenile Diabetes Research Foundation Continuous GlucoseMonitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 2009;32:1378-1383
5. Tamborlane WV, Kollman C, Steffes MW, et al.; Diabetes Research in Children Network (DirecNet) Study Group. Comparison of fingerstick hemoglobin A1C levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes 2005;6:13-16 (Pubitemid 40514886)
6. Diabetes Research in Children Network (DirecNet) Study Group. The accuracy of the Guardian RT continuous glucosemonitor in children with type 1 diabetes. Diabetes Technol Ther 2008;10:266-272
7. Wilson DM, Beck RW, Tamborlane WV, et al.; DirecNet Study Group. The accuracy of the FreeStyle Navigator continuous glucose monitoring system in children with type 1 diabetes. Diabetes Care 2007;30:59-64 (Pubitemid 46061293)
8. Brown RJ, Sinaii N, Rother KI. Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes. Diabetes Care 2008;31:1403-1404
9. Hanas RJ, John G; International HbA Consensus Committee. 2010 consensus statement on the worldwide standardization of the hemoglobin A1C measurement. Pediatr Diabetes 2010;11:209-211
10. Sherr J, Tamborlane WV, Tsalikian E, et al. Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes (Abstract). Diabetes 2011;60(Suppl. 1):A136
11. Cryer PE, Gerich JE. Glucose counter-regulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. N Engl J Med 1985;313:232-241 (Pubitemid 15068639)
12. Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22:1779-1784 (Pubitemid 29521861)
13. Weinzimer SA, Ahern JH, Doyle EA, et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004;114:1601-1605 (Pubitemid 41754924)
14. Scrimgeour L, Cobry E, McFann K, et al. Improved glycemic control after longterm insulin pump use in pediatric patients with type 1 diabetes. Diabetes Technol Ther 2007;9:421-428 (Pubitemid 47585352)
15. Herold KC, Hagopian W, Auger JA, et al. Anti-CD3 monoclonal antibody in newonset type 1 diabetes mellitus. N Engl J Med 2002;346:1692-1698 (Pubitemid 34547482)